AXSM vs ROP · rev $409.6M vs P/E 41, rev $4.20B
Axsome Therapeutics Inc (AXSM) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
AXSM currently screens at market cap $11.96B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the AXSM and ROP stock pages for the full models.
Not investment advice.